Displaying 10 out of 5 results

  1. A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem

    US health regulator approves Teva's migraine drug

    Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine ...
  2. New Content Item

    Teva to hold Indivior generic drug launch pending US ruling

  3. New Content Item

    Teva Pharm to close plant in Israel after no buyer found

  4. NYSE Oct4

    Strong data lift US stocks to fresh records again

  5. NYSE Jan 3

    US stocks begin 2017 with gains

    Wall Street stocks resumed their upward climb on Tuesday, the first trading day of the new year, amid apparent rising optimism about the incoming ...